Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer’s disease (AD) and other ...

Bishnoi Dental Care has conducted 1,000+ outreach camps in Rajasthan, screening 40,000 rural patients and improving dental ...

Post hoc analyses of two Phase 2 trials examine the potential benefits of solengepras, a once-daily, oral, non-dopaminergic ...

Many people do not think about their oral health until they feel pain. They only visit the dentist when a tooth is hurting badly. But most of the time, when pain starts, the problem is already serious ...

If policymakers want to protect access to dental care while managing Medicaid costs, adult dental benefits should not be treated as a go-to option for cuts.

But one dentist has warned that this common flossing mistake could be causing more harm than good to your mouth.

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, Denmark, 10 March 2026 - NMD Pharma A/S, a ...

TIX100 is a specific, orally available TXNIP inhibitor originally developed for its beta-cell protective effects in diabetes. It has received FDA Investigational New Drug approval in diabetes and ...

BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the 2026 International ...

A Tennessee bill to ban water fluoridation statewide has been delayed as lawmakers seek more information before voting. The dental community has warned about what the move could mean for oral health.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...

Drooling can be embarrassing, especially if you’re waking up to a newly minted lover beside you. But if you’re sleeping alone ...